Cargando…

M92. THE OVERLAP BETWEEN PSYCHOTIC SYMPTOMS, SUBSTANCE USE, AND ADVERSITY HISTORY: A SYSTEMATIC REVIEW

BACKGROUND: Research has found that adversity and substance use individually influence the onset of psychosis and its clinical outcomes, though there has been little examination of a potential three-way interaction. An estimated 30–75% of individuals with psychosis have experienced at least one adve...

Descripción completa

Detalles Bibliográficos
Autores principales:	Patterson, Victoria, Pencer, Alissa, Tibbo, Philip
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Poster Session II
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7234600/ http://dx.doi.org/10.1093/schbul/sbaa030.404

Ejemplares similares

M25. CLINICAL CORRELATES OF SUBSTANCE USE IN HEALTHY ADOLESCENTS: ASSOCIATIONS WITH PSYCHOTIC EXPERIENCES AND COGNITIVE BIASES
por: Gago Quintela, Elena Estefania, et al.
Publicado: (2020)

M216. ASSOCIATIONS OF EXTRAPYRAMIDAL SYMPTOMS WITH PSYCHOTIC SYMPTOMS IN A COHORT OF HOMELESS OR PRECARIOUSLY HOUSED PERSONS WITH OR WITHOUT SCHIZOPHRENIA
por: Kim, David, et al.
Publicado: (2020)

M27. FUNCTIONAL OUTCOME OF CHILDREN AND ADOLESCENTS WITH ATTENUATED PSYCHOTIC SYMPTOMS: RESULTS FROM A LONGITUDINAL STUDY
por: Molteni, Silvia, et al.
Publicado: (2020)

M145. ALTERED SUBCORTICAL EMOTIONAL SALIENCE PROCESSING AND A ‘JUMPING TO CONCLUSIONS’ BIAS IN PARKINSON’S PATIENTS WITH PSYCHOTIC SYMPTOMS
por: Knolle, Franziska, et al.
Publicado: (2020)

M28. BIDIRECTIONAL INFLUENCES BETWEEN PSYCHOTIC EXPERIENCES AND SUICIDAL IDEATION IN CHILEAN ADOLESCENTS: THE ROLE OF DEPRESSIVE SYMPTOMS AS MEDIATORS
por: Nunez, Daniel, et al.
Publicado: (2020)

M239. ENVIRONMENTAL POLLUTION AND RISK FOR PSYCHOTIC DISORDERS: AN UPDATE
por: Pauselli, Luca, et al.
Publicado: (2020)

M153. THE RELATION BETWEEN PSYCHOTIC EXPERIENCES AND SLEEP IMPAIRMENTS IN THE GENERAL POPULATION
por: Brederoo, Sanne, et al.
Publicado: (2020)

M242. PREDICTORS OF CRIMINAL SENTIMENTS SCALE (CSS-M) SCORES AMONG OUTPATIENTS WITH PSYCHOTIC DISORDERS
por: Zern, Adria, et al.
Publicado: (2020)

M74. FACIAL EMOTION RECOGNITION ABILITY IN PATIENTS WITH SCHIZOPHRENIA AND OTHER PSYCHOTIC DISORDERS
por: Kjellenberg, Elin, et al.
Publicado: (2020)

M238. CREATION OF A PEER SUPPORT PROGRAM TO SUPPORT TRANSITIONS IN CARE FROM EARLY INTERVENTION SERVICES FOR PSYCHOSIS
por: Crocker, Candice, et al.
Publicado: (2020)

M30. THE ASSOCIATION OF PEER-REPORTED BULLYING AND SOCIAL NETWORK CHARACTERISTICS WITH PSYCHOTIC EXPERIENCES IN CHILDHOOD
por: Steenkamp, Lisa, et al.
Publicado: (2020)

M8. A SYSTEMATIC REVIEW AND META-ANALYSIS OF ENDOCANNABINOID SYSTEM ABNORMALITIES IN PSYCHOTIC ILLNESS
Publicado: (2020)

M87. PREVALENCE OF AUTOIMMUNE DISEASES IN INDIVIDUALS WITH PRIMARY PSYCHOTIC DISORDERS AT BOSTON MEDICAL CENTER
por: Brown, Kayla, et al.
Publicado: (2020)

M129. PATTERNS OF CHILDHOOD TEMPERAMENT ARE ASSOCIATED WITH ADULT PSYCHOTIC DISORDER IN A PROSPECTIVE COHORT STUDY
por: Clarke, Mary, et al.
Publicado: (2020)

M2. STRESS IS ASSOCIATED AND PREDICTS SCHIZOTYPIC AND PSYCHOTIC-LIKE EXPERIENCES IN THE FLOW OF DAILY LIFE IN NONCLINICAL AND INCIPIENT PSYCHOSIS INDIVIDUALS
por: Barrantes-Vidal, Neus, et al.
Publicado: (2020)

M90. CANNABIS USE, CIGARETTE SMOKING, AND PSYCHOTIC EXPERIENCES IN ADOLESCENCE AND DIAGNOSIS OF PSYCHOSIS IN EARLY ADULTHOOD. A BIRTH-COHORT STUDY
por: Peltonen, Teemu, et al.
Publicado: (2020)

M97. PREDICTORS OF TRANSITION TO SCHIZOPHRENIA IN BRIEF PSYCHOTIC DISORDER: FINDINGS FROM A 3-YEAR LONGITUDINAL STUDY IN THE PAFIP COHORT
por: López-Díaz, Álvaro, et al.
Publicado: (2020)

M116. A SYSTEMATIC REVIEW OF THE PSYCHOLOGICAL AND BIOLOGICAL MEDIATORS BETWEEN ADVERSITY AND PSYCHOSIS: POTENTIAL TARGETS FOR TREATMENT
por: Alameda, Luis, et al.
Publicado: (2020)

M194. THE USE OF NOVEL PSYCHOACTIVE SUBSTANCES IN THE PRODROMAL PHASE OF SCHIZOPHRENIA- A CASE SERIES
por: Vasiliu, Octavian
Publicado: (2020)

M159. PSYCHOTIC-LIKE EXPERIENCES, POLYGENIC RISK SCORES FOR SCHIZOPHRENIA AND STRUCTURAL PROPERTIES OF THE SALIENCE, DEFAULT MODE AND CENTRAL-EXECUTIVE NETWORKS IN HEALTHY PARTICIPANTS FROM UK BIOBANK
Publicado: (2020)

M149. THE TOPOGRAPHY OF STRIATAL DOPAMINE AND SYMPTOMS IN PSYCHOSIS: AN INTEGRATIVE PET AND MRI STUDY
por: McCutcheon, Rob, et al.
Publicado: (2020)

M24. NETWORK STRUCTURE OF PSYCHOPATHOLOGY SYMPTOMS IN A COMMUNITY SAMPLE OF YOUTH
por: Wang, Emily, et al.
Publicado: (2020)

M234. QUALITY OF LIFE IN SCHIZOPHRENIA: THE IMPACT OF RESIDUAL SYMPTOMS AND INTERNALIZED STIGMA
por: Hofer, Alex, et al.
Publicado: (2020)

M203. ANTIPSYCHOTIC-LIKE EFFECT OF DOXYCYCLINE IN PSYCHOTOMIMETICS SYMPTOMS INDUCED BY AMPHETAMINE
Publicado: (2020)

M224. LONGITUDINAL DETERIORATION OF GESTURE PERFORMANCE IN SCHIZOPHRENIA IS UNRELATED TO SYMPTOM TRAJECTORIES
por: Pavlidou, Anastasia, et al.
Publicado: (2020)

M217. EFFICACY OF PALIPERIDONE PALMITATE ON PSYCHIATRIC SYMPTOMS AND ATTITUDES TOWARD MEDICATION IN SCHIZOPHRENIA
Publicado: (2020)

M184. SOCIAL SKILLS TRAINING FOR TREATMENT-RESISTANT SCHIZOPHRENIA WITH PREDOMINANTLY NEGATIVE SYMPTOMS
por: Kayo, Monica, et al.
Publicado: (2020)

M233. EXPERIENTIAL NEGATIVE SYMPTOMS ARE MORE PREDICTIVE OF REAL-LIFE FUNCTIONAL OUTCOME THAN EXPRESSIVE NEGATIVE SYMPTOMS IN CLINICAL HIGH-RISK STATES
por: Birkedal Glenthoej, Louise, et al.
Publicado: (2020)

M29. SPECIFIC SYMPTOMS IN ADOLESCENCE PREDICT PSYCHOSIS IN THE NORTHERN FINLAND BIRTH COHORT 1986
por: Palomäki, Johanna, et al.
Publicado: (2020)

M195. LATENT STRUCTURE OF NEGATIVE SYMPTOMS IN EARLY PSYCHOSIS AND CLINICAL HIGH-RISK FOR PSYCHOSIS
por: Chi Yiu Wong, Sandra, et al.
Publicado: (2020)

M95. DSM-5 CLINICIAN-RATED DIMENSIONS OF PSYCHOSIS SYMPTOM SEVERITY: PSYCHOMETRIC PROPERTIES
por: Liemburg, Edith, et al.
Publicado: (2020)

M118. FACTOR STRUCTURE OF THE CLINICIAN-RATED DIMENSION OF PSYCHOSIS SYMPTOM SEVERITY IN PATIENTS WITH EARLY PSYCHOSIS
por: Lee, Kyuyoung, et al.
Publicado: (2020)

M54. ASSOCIATIONS BETWEEN MUSICAL ABILITY SUBSCALE PERFORMANCE, PSYCHIATRIC SYMPTOMS, AND COGNITIVE FUNCTIONING IN SCHIZOPHRENIA
por: Akagawa, Yoshiki, et al.
Publicado: (2020)

A multiple baseline trial of adapted prolonged exposure psychotherapy for individuals with early phase psychosis, comorbid substance misuse, and a history of adversity: A study protocol
por: Patterson, Victoria C., et al.
Publicado: (2022)

M137. HIGH CONFIDENCE FOR VISUOMOTOR ACTION RECRUITS THE VENTRAL STRIATUM – A METACOGNITIVE APPROACH FOR UNDERSTANDING NEGATIVE SYMPTOMS?
por: Bègue, Indrit, et al.
Publicado: (2020)

M44. COGNITIVE REMEDIATION AND PHYSICAL EXERCISE EFFECTS ON NEGATIVE SYMPTOMS AND FUNCTIONALITY IN PATIENTS WITH SCHIZOPHRENIA: A RANDOMIZED CONTROLLED TRIAL
por: Mane, Anna, et al.
Publicado: (2020)

M71. THE INFLUENCE OF METACOGNITIVE CAPACITIES ON SPECIFIC NEGATIVE SYMPTOMS: A SYSTEMATIC REVIEW AND INDIVIDUAL PARTICIPANT META-ANALYSIS OF INTERVIEW-BASED DATA
por: McGuire, Nicola, et al.
Publicado: (2020)

M157. A MULTICENTRE STUDY OF 1H-MRS BRAIN GLUTAMATE LEVELS IN SCHIZOPHRENIA; INVESTIGATING THE EFFECT OF ANTIPSYCHOTIC MEDICATION, SYMPTOM SEVERITY AND AGE
por: Merritt, Kate, et al.
Publicado: (2020)

M172. POLYGENIC RISK SCORES ANALYSES IN ANTIPSYCHOTIC-INDUCED WEIGHT GAIN
por: Yoshida, Kazunari, et al.
Publicado: (2020)

M120. IMPAIRED CLINICAL INSIGHT AS A PREDICTOR OF RELAPSE IN SCHIZOPHRENIA
por: Lindenmayer, Jean-Pierre, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_sbmn7omff8d5gib2l97b5690tt